Literature DB >> 18767071

Pim-1 kinase phosphorylates and stabilizes RUNX3 and alters its subcellular localization.

Hye-Ryun Kim1, Byung-Chul Oh, Joong-Kook Choi, Suk-Chul Bae.   

Abstract

The loci of the Pim and Runx gene families have been identified as targets for viral insertions in CD2-myc mice. Synergistic cooperation between Pim and RUNX was also found in the CD2-Runx2 transgenic mouse lymphoma model. RUNX genes have come to prominence recently because of their roles as essential regulators of cell fate in development. Paradoxically, they appear to function either as tumor-suppressor genes or dominant oncogenes according to the cellular context. However, the molecular mechanism of the ambiguous roles played by this family of transcription factors in cancer has remained largely uninvestigated. Here we demonstrate that Pim-1 phosphorylates four Ser/Thr residues within the Runt domain and stabilizes RUNX3 protein. In addition, Pim-1 markedly altered the cellular localization of RUNX3 from the nucleus to the cytoplasm. Our results demonstrate that the subcellular localization of RUNX3 is altered by phosphorylation. We propose that RUNX family members may behave as oncogenes if mislocalized to a cellular micro-compartment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18767071     DOI: 10.1002/jcb.21906

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  15 in total

1.  Tumor suppressor function of RUNX3 in breast cancer.

Authors:  Lin-Feng Chen
Journal:  J Cell Biochem       Date:  2012-05       Impact factor: 4.429

2.  Inactivation of RUNX3 predicts poor prognosis in esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy.

Authors:  Mo Shi; Zhou Wang; Xiang-Yan Liu; Dong Chen
Journal:  Med Oncol       Date:  2014-11-13       Impact factor: 3.064

Review 3.  Beyond Competitive Inhibition: Regulation of ABC Transporters by Kinases and Protein-Protein Interactions as Potential Mechanisms of Drug-Drug Interactions.

Authors:  Rebecca R Crawford; Praveen K Potukuchi; Erin G Schuetz; John D Schuetz
Journal:  Drug Metab Dispos       Date:  2018-03-07       Impact factor: 3.922

4.  Ubiquilin 1 interacts with Orai1 to regulate calcium mobilization.

Authors:  Jeong-Eun Lee; In-Sook Jeon; Na-Eun Han; Hye-Jin Song; Eung-Gook Kim; Jae-Woon Choi; Ki-Duk Song; Hak-Kyo Lee; Joong-Kook Choi
Journal:  Mol Cells       Date:  2013-01-09       Impact factor: 5.034

5.  Mislocalization of Runt-related transcription factor 3 results in airway inflammation and airway hyper-responsiveness in a murine asthma model.

Authors:  Xiaoyan Zhou; Jinxiao Zhu; Tao Bian; Ruiqian Wang; Fei Gao
Journal:  Exp Ther Med       Date:  2017-07-19       Impact factor: 2.447

6.  PIM kinase isoform specific regulation of MIG6 expression and EGFR signaling in prostate cancer cells.

Authors:  Allan Siu; Carl Virtanen; Jan Jongstra
Journal:  Oncotarget       Date:  2011-12

7.  Role of Runx2 phosphorylation in prostate cancer and association with metastatic disease.

Authors:  C Ge; G Zhao; Y Li; H Li; X Zhao; G Pannone; P Bufo; A Santoro; F Sanguedolce; S Tortorella; M Mattoni; S Papagerakis; E T Keller; R T Franceschi
Journal:  Oncogene       Date:  2015-04-13       Impact factor: 9.867

8.  Src kinase phosphorylates RUNX3 at tyrosine residues and localizes the protein in the cytoplasm.

Authors:  Yun-Mi Goh; Senthilkumar Cinghu; Eileen Tan Hwee Hong; You-Soub Lee; Jang-Hyun Kim; Ju-Won Jang; Ying-Hui Li; Xin-Zi Chi; Kyeong-Sook Lee; Heejun Wee; Yoshiaki Ito; Byung-Chul Oh; Suk-Chul Bae
Journal:  J Biol Chem       Date:  2010-01-25       Impact factor: 5.157

9.  Pim-1 kinase phosphorylates and stabilizes 130 kDa FLT3 and promotes aberrant STAT5 signaling in acute myeloid leukemia with FLT3 internal tandem duplication.

Authors:  Karthika Natarajan; Yingqiu Xie; Mehmet Burcu; Douglas E Linn; Yun Qiu; Maria R Baer
Journal:  PLoS One       Date:  2013-09-05       Impact factor: 3.240

10.  Pim-1 acts as an oncogene in human salivary gland adenoid cystic carcinoma.

Authors:  Xin Zhu; Jia-jie Xu; Si-si Hu; Jian-guo Feng; Lie-hao Jiang; Xiu-xiu Hou; Jun Cao; Jing Han; Zhi-qiang Ling; Ming-hua Ge
Journal:  J Exp Clin Cancer Res       Date:  2014-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.